Aerovate Therapeutics, Inc. (AVTE) Unrecognized Tax Benefits USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Aerovate Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from 2020 to 2023.
  • Aerovate Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $2.21 M, a 123% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.21 M +$1.22 M +123% Dec 31, 2023 10-K 2024-03-25
Q4 2022 $993 K +$464 K +87.7% Dec 31, 2022 10-K 2024-03-25
Q4 2021 $529 K +$253 K +91.7% Dec 31, 2021 10-K 2024-03-25
Q4 2020 $276 K Dec 31, 2020 10-K 2023-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.